Hacker News Reader

Chimpanzee adenovirus-vectored Oxford vaccine #1, targeting novel coronavirus 2019 (aka SARS-CoV-2).

Seems pretty well-named.

It's accurately named. All I can say is "well-named" is in the eye of the beholder, and I'm fairly certain you're not in marketing.

It won't get a trade name until it goes to market.

We just don't normally hear about pre-market drugs in mainstream media.